Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial
C. Schilder(Radboud University Nijmegen), Sanne B. Schagen(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Sabine C. Linn(Oncode Institute), Willem Boogerd(The Netherlands Cancer Institute), Caroline Seynaeve(Radboud University Nijmegen), L.V.A.M. Beex, F. S. van Dam(Radboud University Nijmegen), J.W.R. Nortier(Radboud University Nijmegen), Chad M. Gundy(Radboud University Nijmegen), Cornelis JH van de Velde(Leiden University), Hilde M. Huizenga(Radboud University Nijmegen)
Cited by 261
Related Papers
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Gastric cancer
|The Lancet|2009|890
Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy
|JNCI Journal of the National Cancer Institute|1998|768
Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.
|Journal of Clinical Oncology|1993|552
Preoperative chemotherapy for women with operable breast cancer
|Cochrane Database of Systematic Reviews|2007|408